|
⚲
|
| Keyboard |
| Carlyle Investment Management LLC
✚
|
|
|---|---|
| CRD # | 111128 |
| SEC # | 801-52462 |
| CIK # | 0001354120, 0001527166 |
| AUM | 283.81 B (2026-03-31) |
| Employees | 1,040 (30% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 202-729-5626 |
| Address | 1001 Pennsylvania Avenue, NW Washington, DC 20004-2505 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] [Instagram] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (7/7/2026) [Brochure] |
|---|
Item 5. Fees and Compensation CIM or its affiliates 4 generally receive management fees, incentive fees, carried interest or similar profit allocations from Advisory Clients. Advisory Clients frequently also indirectly incur or generate other fees payable to CIM or its affiliates, depending on the nature of their portfolio activities. CIM or its affiliates, for example, earn fees and other compensation from prospective and actual portfolio companies, purchasers, sellers and other parties as compensation for services (collectively, “Service Fees”). These Service Fees can include project, structuring, topping, termination, break-up, directors’, organizational, set-up, investment banking, underwriting, syndication, closing, commitment, advisory, consulting, amendment, servicing, and other similar fees in connection with the purchase, monitoring, or disposition of underlying investments (including warrants, options, derivatives and other rights in respect of securities) or from unconsummated transactions. In general, the specific legal and/or organizational documents of the relevant Advisory Client, the investment management agreement between CIM (or an affiliate) and such Advisory Client or the agreements in respect of the portfolio investments describe the basic fee structure relevant to the investors in such Advisory Client. To the extent provided in such organizational documents or investment management agreement, CIM’s management fees from Advisory Clients generally are reduced (offset) by a specified portion of the Service Fees that arise out of such Advisory Client’s investment activities. The Service Fees can be and often are substantial, and if not fully offset pursuant to organizational documents will be indirectly borne by investors. Certain fees are excluded from the definition of “Service Fees” and not subject to a management fee offset. For certain Advisory Clients, capital markets fees earned by GCM (which includes a broker-dealer affiliate of CIM that is a U.S.-registered broker-dealer and other affiliates providing similar services with respect to loans) for conducting a financial services, loan origination, structuring, placement or other similar business, including, for example, as a broker, dealer, distributor, syndicator, arranger, servicer or originator of securities or loans, are not considered “Service Fees” subject to any management fee offset. As described in more detail below, these capital markets fees include offering, placement, financing, syndication, capital structure advisory, turnaround, workout, underwriting, solicitation, investment banking, currency, hedging, structuring, loan agent, loan servicing, rating advisory or similar fees in connection with the activities of an Advisory Client and its portfolio companies, including with respect to an initial public offering or private placement, the arranging or provision of credit facilities (including any related extensions or refinancing) for an Advisory Client or one of its portfolio companies and other vehicles managed or controlled by Carlyle, the placing of co-investment, the distribution or For the purposes of this Brochure, references to “CIM or its affiliates” or “CIM and its affiliates” do not include references to Carlyle-affiliated advisers, such as CGCIM, AlpInvest, CASP and CAPDP, unaffiliated advisers, such as Atlas NV, NGP and Riverstone, or any Carlyle portfolio companies, including portfolio companies that are investment advisers registered with the SEC (e.g., Content Partners LLC, or the separately registered investment advisers affiliated with TCW Group, Inc.). placement of loans or equity securities of an Advisory Client portfolio company or otherwise arranging or providing financing for such portfolio company alone or with other lenders, which could include other vehicles managed or controlled by Carlyle (any such fees, “GCM Fees”). GCM may manage or otherwise participate in underwriting syndicates and/or selling groups with respect to the securities and/or loans and debt instruments of portfolio companies and other non-controlled entities in or through which certain Advisory Clients invest, including in respect of securities or other instruments of such portfolio companies in which Advisory Clients have not invested. GCM also manages or otherwise participates in underwriting syndicates and/or selling groups with respect to securities and/or loans and other instruments held directly or indirectly by certain co- investment vehicles. Further, GCM will be involved in the public offering or private placement of such securities and/or loans and other instruments, and/or sometimes provide capital markets advisory services to portfolio companies and other non-controlled entities in or through which Advisory Clients invest, including in connection with mergers, acquisitions, and restructurings; and will alone, or with other counterparties, provide acquisition financing, lines of credit and other corporate lending or financing products and services to such entities in addition to financing provided through an Advisory Client’s investment. In addition, certain of Carlyle’s investment advisory professionals will be involved in such activities of GCM, and their activities are expected to give rise to GCM Fees that are not subject to any management fee offset, even though such persons are involved in investment-related activities on behalf of one or more Advisory Clients. In addition, fees attributable to co-investors or internal or external co-investment vehicles and fees eligible to be treated as expenses of an Advisory Client are expected to also be retained by Carlyle and its affiliates, including GCM, and excluded from “Service Fees” and not subject to a management fee offset. Other than transactions expressly permitted by the governing agreements of the relevant Advisory Client, any fees paid to CIM or its affiliates by a portfolio company or an Advisory Client are ... |
| Account Minimums and Types of Clients — Form ADV Part 2A (7/7/2026) [Brochure] |
|---|
Item 7. Types of Clients The vast majority of CIM’s Advisory Clients are pooled investment vehicles. CIM also provides advisory services on a separately managed account basis to, among others, entities associated with non-U.S. and U.S. state and local governments and their instrumentalities. CIM also provides other advisory, sub-advisory and co-advisory services as described above. CIM and its affiliates typically require that each third-party investor in an Advisory Client be an “accredited investor” as defined in Regulation D under the Securities Act and a “qualified purchaser” as defined in the 1940 Act. Typically, a minimum investment amount is imposed on third parties investing in the investment vehicles for which CIM acts as investment adviser or collateral manager (through its relying advisers, including ALLP, Carlyle CLO, CBAM CLO and Carlyle CLO Europe). This minimum often is set at $5-10 million, but can be subject to a reduction upon prior agreement by CIM or an affiliate (subject to applicable legal requirements) and is often much lower for investment vehicles targeted at high-net worth individuals. A minimum investment amount can also be established pursuant to the laws of the jurisdiction in which the investment vehicle was established. |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Medline Inc | 8.3 | ||
| Standardaero Inc | 2.2 | ||
| Phathom Pharmaceuticals Inc | 0.0 | ||
| PONY AI Inc | 0.0 | ||
| Invitation Homes Inc | 0.0 | ||
| U-Store-It Trust | 0.0 | ||
| Homology Medicines Inc | 0.0 | ||
| Getty Images Holdings Inc | 0.0 | ||
| Spruce Biosciences Inc | 0.0 | ||
| Forward Air Corp | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Abingworth Clinical Co-Development Fund 3 | [2026-03-31] | 65.9 M | |
| Filed 2025-06-25 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $6,000,000 · Revenue Decline to Disclose | ||||
| PE | ACCD 3 SMRS Co-Invest LP | 2026-03-31 | ||
| PE | Carlyle Bluebird SMA LP | 2026-03-31 | ||
| SA | Carlyle Euro CLO 2013-1 DAC | 2026-03-31 | 540.9 M | |
| SA | Carlyle Euro CLO 2025-1 DAC | 2026-03-31 | 744.7 M | |
| SA | Carlyle Euro CLO 2025-2 DAC | 2026-03-31 | 596.1 M | |
| SA | Carlyle Euro CLO 2025-CE DAC | 2026-03-31 | 263.7 M | |
| SA | Carlyle Euro CLO 2025-DE DAC | 2026-03-31 | 100.8 M | |
| RE | Carlyle Europe Realty Fund III | 2026-03-31 | ||
| PE | Carlyle Global Infrastructure Opportunity Fund II | 2026-03-31 | ||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 595 | 203.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 1 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 15 | 80.4 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 1 | 0.0 |
| Total | 612 | 283.8 |
| By Discretionary | ||
| Discretionary | 602 | 200.8 |
| Non-Discretionary | 10 | 83.1 |
| Total | 612 | 283.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 122.6 | |
| United States Persons | 161.2 | |
| Total | 612 | 283.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Sean Flynn | Director | 165 | 41 | |
| Patrick Harrigan | Director | 135 | 40 | |
| Tej Gujadhur | Director | 51 | 16 | |
| Laurence Tosi | Executive Officer | 167 | 14 | |
| Santosh Gujadhur | Director | 29 | 10 | |
| Jonathan Gray | Executive Officer | 94 | 9 | |
| Anthony Beovich | Executive Officer | 172 | 8 | |
| Dennis McDonagh | Executive Officer | 40 | 7 | |
| Michael Nash | Executive Officer | 53 | 6 | |
| Judy Turchin | Executive Officer | 42 | 6 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001354120] | |
| 3 | [0001354120] | |
| 4 | [0001354120] | |
| SC 13D | [0001354120] | |
| SC 13G | [0001354120] | |
| 10-K | [0001527166] | |
| 10-Q | [0001527166] | |
| 13F-HR | [0001527166] | |
| 3 | [0001527166] | |
| 4 | [0001527166] | |
| 8-K | [0001527166] | |
| SC 13D | [0001527166] | |
| SC 13G | [0001527166] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $107.7B |
| Clients | 16 (67 non-US) |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity, Real Estate |
| LEI | 549300MVJ5FAYQX68835 |
| Related People Network |
|---|
| 132 people file Form D offerings alongside this firm's people, tied to 28 other firms through shared filers. |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Carlyle Group Inc CG
Common Stock
|
2026-03-19 | Sell | 500,000 | $46.68 | 23,340,000 |
|
Carlyle Group Inc CG
Common Stock
|
2026-03-19 | Gift | 100,000 | $0.00 | |
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-10 | Other | 2,113,483 | ||
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-10 | Sell | 26,105,840 | $41.00 | 1,070,339,440 |
|
Medline Inc MDLN
Class B Common Stock
|
2026-03-05 | Other | 1,212,767 | ||
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-05 | Conversion | 1,212,767 | ||
|
Medline Inc MDLN
Common Units of Medline Holdings, LP · derivative
|
2026-03-05 | Conversion | 1,212,767 | $0.00 | |
|
Medline Inc MDLN
Class B Common Stock
|
2026-03-04 | Other | 8,085,116 | ||
|
Medline Inc MDLN
Common Units of Medline Holdings, LP · derivative
|
2026-03-04 | Conversion | 8,085,116 | $0.00 | |
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-04 | Conversion | 8,085,116 | ||
|
StandardAero Inc SARO
Common Stock
|
2026-02-26 | Sell | 19,840,268 | $31.46 | 624,174,831 |
|
Carlyle Group Inc CG
Common Stock
|
2026-02-20 | Grant | 3,431 | $0.00 | |
|
Carlyle Group Inc CG
Common Stock
|
2026-02-20 | Grant | 6,424 | $0.00 | |
|
Carlyle Group Inc CG
Common Stock
|
2026-02-20 | Grant | 343 | $0.00 | |
|
Carlyle Group Inc CG
Common Stock
|
2026-02-20 | Grant | 9,114 | $0.00 | |
|
Carlyle Group Inc CG
Common Stock
|
2026-02-20 | Grant | 17,457 | $0.00 | |
|
Carlyle Group Inc CG
Common Stock
|
2026-02-20 | Grant | 1,070 | $0.00 | |
|
Carlyle Group Inc CG
Common Stock
|
2026-02-20 | Grant | 2,625 | $0.00 | |
|
Carlyle Group Inc CG
Common Stock
|
2026-02-20 | Grant | 6,507 | $0.00 | |
|
Carlyle Group Inc CG
Common Stock
|
2026-02-14 | Tax withheld | 134,812 | $54.49 | 7,345,906 |
| showing 20 of 200 most recent transactions | |||||
| Related Firms | State | AUM |
|---|---|---|
|
Carlyle Investment Management LLC
✚
|
DC | 283.81 B |
|
Carlyle Global Credit Investment Management LLC
✚
|
NY | 68.38 B |
|
AlpInvest Partners BV
✚
|
39.88 B | |
|
Carlyle Aviation Securities Partners LLC
✚
|
FL | 1,136.0 M |
| Comparable Firms | State | AUM |
|---|---|---|
|
Ares Management LLC
✚
|
CA | 458.82 B |
|
Point72 Asset Management LP
✚
|
CT | 274.10 B |
|
HPS Investment Partners LLC
✚
|
NY | 175.72 B |
|
Nuveen Alternatives Advisors LLC
✚
|
NY | 142.02 B |
|
APG Asset Management US Inc
✚
|
NY | 141.33 B |
|
Corebridge Institutional Investments US LLC
✚
|
NJ | 121.05 B |
|
Angelo Gordon & Co LP
✚
|
NY | 115.94 B |
|
StepStone Group LP
✚
|
CA | 107.82 B |
|
Brookfield Asset Management PIC US LLC
✚
|
NY | 105.30 B |
|
Oak Hill Advisors LP
✚
|
NY | 100.72 B |